Lycia Therapeutics, Inc. is a biotechnology company leveraging its lysosomal targeting chimera (LYTAC) platform from Founder and Chemistry Nobel Laureate 2022, Carolyn Bertozzi, to discover and develop first-in-class therapeutics that degrade extracellular and membrane-bound proteins. Lycia’s next generation degraders harness the cell’s endogenous lysosomal trafficking and degradation machinery with the potential to degrade targets previously considered to be intractable, across a spectrum of indications. After raising $105 million in capital in 2021, Lycia is advancing an internal pipeline of novel degraders and has entered a strategic collaboration with Eli Lilly to address key unmet medical needs. In May 2024, Lycia Therapeutics completed a $106.6 million series C financing to advance its pipeline of LYTAC extracellular protein degraders to the clinic. Lycia is headquartered in South San Francisco.
Visit https://lyciatx.com/ for more information.
The Role:
Lycia Therapeutics is seeking a self-motivated, organized, and technically skilled in vivo pharmacology Research Associate II or Senior Research Associate. The successful applicant will engage in innovative research in a dynamic team environment, with a focus on developing and executing in vivo studies to support target validation and drug discovery efforts. A passion for translating basic scientific insights into generation of novel therapeutics is a must.
We are an equal opportunity employer and value diversity at our company. We do not discriminate on the basis of race, religion, color, national origin, gender, sexual orientation, age, marital status, veteran status, or disability status
If an employer mentions a salary or salary range on their job, we display it as an "Employer Estimate". If a job has no salary data, Rise displays an estimate if available.
Lycia Therapeutics, Inc. is excited to announce a fantastic opportunity for a Research Associate II or Senior Research Associate in In-Vivo Pharmacology based in South San Francisco. We're a pioneering biotechnology company, leveraging revolutionary technology to develop first-in-class therapeutics that can degrade extracellular and membrane-bound proteins. If you have a knack for innovative research and a desire to translate basic scientific insights into groundbreaking therapies, this role might be your perfect match! As part of our dynamic in vivo pharmacology team, you will conduct critical studies evaluating pharmacokinetics, pharmacodynamics, efficacy, and much more. Your tasks will range from study design and drug administration to tissue processing and IVIS imaging. This is a unique opportunity to collaborate within cross-functional teams, driving our drug discovery efforts forward. We’re looking for someone with a degree in biology or a related field, with experience and proficiency in animal handling and a passion for learning new techniques. You’ll need to be detail-oriented, organized, and a superb communicator. With an expected salary range of $87,000 to $115,000 based on experience and qualifications, it's an exciting time to join us at Lycia, especially as we advance our pipeline of innovative therapies. Come be part of something special and help shape the future of medicine!
Subscribe to Rise newsletter